This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4lvg
From Proteopedia
(Difference between revisions)
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)== | |
| + | <StructureSection load='4lvg' size='340' side='right'caption='[[4lvg]], [[Resolution|resolution]] 1.70Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4lvg]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LVG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4LVG FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.702Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=20O:(1S,2S)-N-[4-(PHENYLSULFONYL)PHENYL]-2-(PYRIDIN-3-YL)CYCLOPROPANECARBOXAMIDE'>20O</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4lvg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lvg OCA], [https://pdbe.org/4lvg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4lvg RCSB], [https://www.ebi.ac.uk/pdbsum/4lvg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4lvg ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity). | ||
| - | + | ==See Also== | |
| - | + | *[[Phosphoribosyltransferase 3D structures|Phosphoribosyltransferase 3D structures]] | |
| - | + | __TOC__ | |
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Bravo B]] | ||
| + | [[Category: Dragovich PS]] | ||
| + | [[Category: Feng Y]] | ||
| + | [[Category: Giannetti AM]] | ||
| + | [[Category: Gunzner-Toste J]] | ||
| + | [[Category: Ho Y]] | ||
| + | [[Category: Hua R]] | ||
| + | [[Category: Liederer BM]] | ||
| + | [[Category: Liu Y]] | ||
| + | [[Category: O'Brien T]] | ||
| + | [[Category: Oeh J]] | ||
| + | [[Category: Sampath D]] | ||
| + | [[Category: Shen Y]] | ||
| + | [[Category: Skelton N]] | ||
| + | [[Category: Wang C]] | ||
| + | [[Category: Wang L]] | ||
| + | [[Category: Wang W]] | ||
| + | [[Category: Wu H]] | ||
| + | [[Category: Xiao Y]] | ||
| + | [[Category: Yuen P]] | ||
| + | [[Category: Zak M]] | ||
| + | [[Category: Zhao G]] | ||
| + | [[Category: Zhao Q]] | ||
| + | [[Category: Zheng X]] | ||
Current revision
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)
| |||||||||||
Categories: Homo sapiens | Large Structures | Bravo B | Dragovich PS | Feng Y | Giannetti AM | Gunzner-Toste J | Ho Y | Hua R | Liederer BM | Liu Y | O'Brien T | Oeh J | Sampath D | Shen Y | Skelton N | Wang C | Wang L | Wang W | Wu H | Xiao Y | Yuen P | Zak M | Zhao G | Zhao Q | Zheng X
